Home/ Supplements/ Nac/ Liver/Kidney Detox

Liver/Kidney Detox

product on market Capsule Vinco Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains milk thistle and N-acetyl cysteine, which have moderate evidence for supporting liver function and antioxidant defense. Dandelion root and schisandra berry are included for their traditional diuretic and hepatoprotective properties, though clinical evidence for these is more limited. The ingredient profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Liver/Kidney Detox
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Vegetable Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
29%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 600.0mg (7 products) 39 studies (A:2, B:13)
Market median: 300.0mg (159 products)
Market median: 250.0mg (562 products) 55 studies (A:0, B:19)
Market median: 650.0mg (87 products) 1 studies — no high-quality reviews
Phyllanthus amarus extract
100 mg
Uva Ursi
100 mg
Bupleurum root extract
50 mg

Other Ingredients

Cellulose Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use: as a dietary supplement for adults and children twelve or more years of age, take three capsules per day, or as directed by a qualified healthcare professional.

Warnings & Precautions

Keep out of reach of children.

Tamper resistant. Do not purchase if seal is broken.

Formulation Notes

The ingredients found in Vinco’s Liver/Kidney Detox have been shown to be beneficial in support of liver and kidney detoxification.

Made in USA

Detoxification support

Gluten free

No wheat, no gluten, no corn, no dairy, no soy, yeast free

Additional Information

Store in a cool, dry place.

Professional formulation

Metadata

Product Details

UPC / SKU7 39930 27506 5
DSLD Entry Date2023-08-23
Product TypeOther Combinations
FormCapsule
BrandVinco
DSLD ID295256
Data Updated2026-04-11
Research

Research Evidence

41
Research Sources
51
Avg Quality
19
Rct
13
Meta Analysis
9
Clinical Trial
B N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
B Effect of high-dose N-acetylcysteine on exacerbations and lung function in patients with mild-to-moderate COPD: a double-blind, parallel group, multicentre randomised clinical trial
Rct Nature communications 2024 PubMed DOI
B N-acetylcysteine for non-paracetamol (acetaminophen)-related acute liver failure
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis
Meta Analysis European respiratory review : an official journal of the European Respiratory Society 2015 PubMed DOI
B A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
Rct BMC medicine 2019 PubMed DOI
B Efficacy of N-acetylcysteine for patients with depression: An updated systematic review and meta-analysis
Meta Analysis General hospital psychiatry 2024 PubMed DOI
B Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates
Meta Analysis The Cochrane database of systematic reviews 2006 PubMed
B N-acetylcysteine as an adjunctive treatment for bipolar depression: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Bipolar disorders 2021 PubMed DOI
B N-acetylcysteine as an adjunctive treatment for bipolar depression and major depressive disorder: a systematic review and meta-analysis of double-blind, randomized placebo-controlled trials
Meta Analysis Psychopharmacology 2020 PubMed DOI
B N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Meta Analysis Archivos de bronconeumologia 2024 PubMed DOI
View all evidence for Nac →
Compare

Similar Products

View all Nac products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.